Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aconite aqueous extract inhibits the growth of hepatocellular carcinoma through CCL2-dependent enhancement of natural killer cell infiltration
Kang-di Yang, Xu Dong Zhang, Ming-cong Shao, et al.
Journal of Integrative Medicine (2023) Vol. 21, Iss. 6, pp. 575-583
Closed Access | Times Cited: 13

Showing 13 citing articles:

Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1
Kejia Lv, Sizhe Yu, Yu Wang, et al.
Cellular Signalling (2024), pp. 111378-111378
Open Access | Times Cited: 6
EHF promotes liver cancer progression by meditating IL-6 secretion through transcription regulation of KDM2B in TAMs
Wei Song, Siqi Zhao, Wei‐Jun Yang, et al.
Cellular Signalling (2025) Vol. 129, pp. 111670-111670
Closed Access
Chemokines: Orchestration of the Tumor Microenvironment and Control of Hepatocellular Carcinoma Progression
Jiezuan Yang, Haifeng Lu, Lanjuan Li
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
The progress of natural killer cells in the treatment of immune response to hepatocellular carcinoma

New medicine. (2025), pp. 1-7
Closed Access
Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population
Hung-Kai Chen, Kai‐Cheng Chang, Shih‐Chieh Shao, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 879-890
Open Access
Cell membrane derived biomimetic nanomedicine for precision delivery of traditional Chinese medicine in cancer therapy
Hang Xiao, Faisal Raza, Kunwei Li, et al.
Journal of Controlled Release (2025), pp. 113829-113829
Closed Access
Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects.
Eman H. Yousef, Amal M. El Gayar, Nada F. Abo El‐Magd
Critical Reviews in Oncology/Hematology (2025), pp. 104765-104765
Closed Access
Traditional Chinese herbal medicine: harnessing dendritic cells for anti-tumor benefits
Mengyi Shen, Zhen Li, Jing Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment
Xie Ruishi, Xu Linyi, Bai Yunfan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Extracellular Vesicles in the HCC Microenvironment: Implications for Therapy and Biomarkers
Le Cheng, Limin Zhang, Xiaoxiao Wang, et al.
Pharmacological Research (2024), pp. 107419-107419
Open Access | Times Cited: 1
Bioinformatics-Based Construction of Immune-Related microRNA and mRNA Prognostic Models for Hepatocellular Carcinoma
Ying Chen, Dian Yin, Xiu Feng, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 1793-1811
Open Access | Times Cited: 1
GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway
Shuangshuang Yang, Y. Liu, Bushi Zhang, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024)
Open Access
Higher Expression of Ku80 and Ku70 Indicates Hotter Tumor Immune Microenvironment in Hepatocellular Carcinoma and Better CTL-Centered Immunotherapy
Lukun Yang, Ling Li, Peiping Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 9511-9525
Open Access
Page 1

Scroll to top